Inflammatory Bowel Syndrome includes the diagnosis of Crohn’s disease and Ulcerative Colitis, and also includes other non-specific causes of colitis (bowel inflammation).
Status of medication in sport
Medical management of the condition can include the use of oral or rectal glucocorticoids (e.g. Prednisolone). Glucocorticoids are prohibited in-competition and require a Therapeutic Use Exemption (TUE) if used during, or just prior to competition periods.
What information is required for a TUE application?
- A completed TUE application form signed by the treating doctor and athlete.
- Detailed typed clinical letter(s) from treating specialist(s) that includes:
- diagnosis – summary of clinical history leading to diagnosis
- age of diagnosis and management to date
- results of colonoscopy/gastroscopy and histological reports as appropriate, and
- current treatment, including route, dose and frequency of all medications.
NOTE: A clinical letter can be a copy of a specialist’s letter to another doctor (e.g. a GP), and at least one of the clinical letters submitted with the application must have been written in the last 12 months.
- Supplementary reports (if available) that support the diagnosis, including blood test results (that might show evidence of anaemia or inflammation).
For additional information please refer to the medical information relating to the condition on the WADA website.